ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ARPOD-CV DRY SYP

FERTEK-XT

Product Packing: 200 ML

Product Composition: Ferrous Bisglycinate 30 mg + Folic acid 550 mcg + Zinc 5 mg + Cyanocobalamin 2 mcg

Product Price: MRP : 141

FERTEK-XT

Ferrous Bisglycinate 30 mg + Folic Acid 550 mcg + Zinc 5 mg + Cyanocobalamin 2 mcg | SYP 200 ML

FERTEK-XT is an oral hematinic and nutritional syrup containing Ferrous Bisglycinate, Folic Acid, Zinc and Cyanocobalamin. These nutrients support normal red blood cell formation, hemoglobin synthesis and nutritional requirements when supplementation is clinically appropriate.

Iron is required for hemoglobin and oxygen transport; Folic Acid and Vitamin B12 participate in normal DNA synthesis and red blood cell formation; Zinc supports numerous enzyme systems and normal immune function. The supplied strengths are preserved exactly, but because no per-volume basis was supplied, the exact concentration per ml or measured dose must be verified from the approved product label.

Composition

Each labelled dose contains:

·         Ferrous Bisglycinate - 30 mg | Folic Acid - 550 mcg

·         Zinc - 5 mg | Cyanocobalamin (Vitamin B12) - 2 mcg

·         Syrup base / excipients - q.s. The supplied brief gives ingredient strengths but does not state the measured volume to which they apply; exact concentration per ml/measured dose must be verified from the approved product label.

Dosage form: Oral Syrup

Pack size: 200 ml

Uses of FERTEK-XT

FERTEK-XT may be used as a hematinic/nutritional supplement where iron, folate, Vitamin B12 and Zinc supplementation is appropriate according to the approved label and healthcare professional guidance.

·         Supports normal hemoglobin synthesis and red blood cell formation through iron supplementation

·         Folic Acid and Vitamin B12 support normal DNA synthesis and maturation of red blood cells

·         Zinc supports normal enzyme activity, immune function and general nutritional requirements

·         May help correct or prevent nutrient deficiency when the underlying need has been appropriately assessed

Fatigue, pallor, persistent weakness or suspected anemia should be medically evaluated because treatment depends on the cause and laboratory findings.

How FERTEK-XT Works

FERTEK-XT combines four nutrients with complementary hematinic and nutritional roles:

Ferrous Bisglycinate: Provides iron required for hemoglobin formation and oxygen transport. Its chelated form is used as an oral iron source.

Folic Acid: Supports one-carbon metabolism, DNA synthesis and normal red blood cell production.

Cyanocobalamin (Vitamin B12): Supports normal DNA synthesis, neurologic function and red blood cell formation.

Zinc: Acts as a cofactor for many enzymes and contributes to normal immune, cellular and tissue functions.

Clinical response depends on the cause and severity of deficiency, absorption, dose, adherence and correction of underlying causes such as blood loss or malabsorption.

 

Dosage and Direction for Use

Use FERTEK-XT according to the approved product label or healthcare professional's advice. The supplied brief lists Ferrous Bisglycinate 30 mg, Folic Acid 550 mcg, Zinc 5 mg and Cyanocobalamin 2 mcg but does not state the volume containing these strengths, so no per-ml or per-5-ml dose has been inferred.

Measure the recommended quantity accurately with a calibrated measuring cup, spoon or oral syringe as appropriate.

Iron absorption can be reduced by some foods, antacids and mineral-containing products; follow product-specific administration advice and separate interacting medicines when professionally advised.

Do not exceed the recommended dose. Iron-containing products must be stored securely away from children because accidental overdose can be dangerous.

Possible Side Effects

Possible effects of iron- and mineral-containing supplements may include:

·         Nausea, abdominal discomfort, constipation, diarrhoea or heartburn

·         Darkening of stools is common with oral iron and is usually expected; however, gastrointestinal bleeding should not be assumed to be harmless

·         Metallic taste or gastrointestinal irritation may occur in some users

·         Allergic or hypersensitivity reactions are uncommon but possible with active ingredients or excipients

·         Seek urgent medical attention for suspected iron overdose, severe abdominal symptoms, repeated vomiting, significant allergic reaction or other serious symptoms.

Any persistent or troublesome adverse effect should be discussed with a healthcare professional.

Precautions and Contraindications

·         Confirm the cause of anemia or nutrient deficiency before prolonged supplementation, particularly when symptoms are persistent or recurrent.

·         Avoid use in patients with known hypersensitivity to any ingredient or in iron-overload states unless specifically directed by a healthcare professional.

·         Iron supplementation requires caution in conditions involving iron accumulation, repeated transfusions or certain chronic diseases; laboratory monitoring may be appropriate.

·         Folic Acid can improve hematologic findings while neurologic injury from unrecognized Vitamin B12 deficiency progresses; B12 status should be considered where clinically relevant.

·         Patients with significant gastrointestinal, kidney or liver disease, pregnancy, breastfeeding, infants and children require individualized professional guidance.

·         Do not combine with other iron, folate, B12 or Zinc supplements without considering the total daily intake.

·         Check sweeteners, flavours, preservatives and potential allergens on the final approved label.

·         Keep out of reach of children and store according to the approved pack instructions.

·         Drug Interaction Considerations

·         Oral iron and Zinc can reduce absorption of medicines such as tetracycline or quinolone antibiotics and levothyroxine; spacing may be required. Antacids and some mineral supplements can reduce iron absorption. Folic Acid may interact with certain antifolate or antiepileptic medicines. Check current medicine-specific guidance.

·         Provide the healthcare professional with a complete list of prescription medicines, OTC products and nutritional supplements before regular use.

Business Growth Opportunity with FERTEK-XT

FERTEK-XT offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add an iron, folate, Zinc and Vitamin B12 oral syrup in a convenient 200 ml pack to their hematinic and nutritional-support portfolio.

Hematinic supplementation is an established healthcare segment. Promotion should remain consistent with the approved composition, permitted claims, ethical pharmaceutical practice and applicable regulations.

 

Key Business Advantages

·         Four-component hematinic and nutritional formulation

·         Ferrous Bisglycinate + Folic Acid + Zinc + Cyanocobalamin

·         Convenient oral syrup dosage form

·         200 ml pack

·         Suitable addition to hematinic and nutritional-support portfolios subject to approved formulation and claims

·         Opportunity for ethical promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for FERTEK-XT

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for FERTEK-XT in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for FERTEK-XT and other quality-focused healthcare products.

Third-Party Manufacturing Support for Ferrous Bisglycinate + Folic Acid + Zinc + Cyanocobalamin Syrup

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to FERTEK-XT under their own brand, subject to applicable licensing, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

·         Customized approved strengths, flavour and pack requirements, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies and healthcare brands seeking to expand a hematinic oral-syrup portfolio.

Frequently Asked Questions About FERTEK-XT

1. What is FERTEK-XT?

FERTEK-XT is a 200 ml oral syrup containing Ferrous Bisglycinate 30 mg, Folic Acid 550 mcg, Zinc 5 mg and Cyanocobalamin 2 mcg according to the supplied product brief.

2. What is FERTEK-XT used for?

It may be used as a hematinic/nutritional supplement where iron, folate, Vitamin B12 and Zinc supplementation is appropriate according to the approved label and professional guidance.

3. What is Ferrous Bisglycinate?

Ferrous Bisglycinate is a chelated oral iron source that supplies iron required for normal hemoglobin formation and oxygen transport.

4. Why are Folic Acid and Vitamin B12 included?

Folate and Vitamin B12 participate in normal DNA synthesis and red blood cell formation. Their clinical use should be guided by nutritional need and the underlying cause of deficiency.

5. Can FERTEK-XT cause dark stools?

Yes. Oral iron commonly darkens stools. Persistent concerning gastrointestinal symptoms or suspected bleeding should still be medically assessed.

6. How should FERTEK-XT be taken?

Follow the approved label or healthcare professional's directions. The supplied strengths have no stated per-volume basis, so the exact measured dose must be verified from the approved label.

7. Is a PCD Pharma Franchise available for FERTEK-XT?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Ferrous Bisglycinate + Folic Acid + Zinc + Cyanocobalamin syrup may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable licensing and regulatory requirements.

Disclaimer

FERTEK-XT product information in this document is for general professional and business information. The supplied product brief states Ferrous Bisglycinate 30 mg + Folic Acid 550 mcg + Zinc 5 mg + Cyanocobalamin 2 mcg, SYP 200 ML, but does not state the measured volume to which these strengths apply. No per-ml or per-5-ml concentration has therefore been inferred. Exact composition, concentration per measured dose, approved age range, indications, dosage, contraindications, warnings, interactions, excipients and regulatory status must be verified against the current approved product label before manufacture, promotion, recommending, dispensing or use. Iron overdose can be dangerous, especially in children. Suspected anemia or persistent symptoms require appropriate clinical assessment. This document is not a substitute for professional medical advice.

Contact